Company presentation - Mondobiotech

More documents

Recommendations

Info

Founders’ vision “for us, <strong>Mondobiotech</strong> is a long term project for changing the world of medicine in rare and neglected diseases.” (Fabio, Dorian, Patrick, Vera) 4/33
Value drivers of our business • In the classical pharmaceutical and biotech field there is no correlation between resources invested in R&D and the resulting output obtained, at least not measurable in the numbers of new medicaments. Therefore, the development process is probably characterised by other value drivers. • We believe that in-depth information exchange, interaction, versatility and flexibility are such value drivers. Therefore, we operate with a continuously expanding community (scientists, physicians, patients, patient advocacy organisations etc.) who share their experience, know-how, expertise and skills with us and who, like us, are dedicated to the search of treatments for rare and neglected diseases (the “<strong>Mondobiotech</strong> community”). + + + connect partecipate collaborate discuss 5/33
Page 1 and 2: Introduction to our business, Augus
Page 3: The context 30’000 is the total n
Page 7 and 8: Key competitive strength Dry search
Page 9 and 10: Model validation For our vision, bu
Page 11 and 12: Search & Match 312 medicaments for
Page 13 and 14: IP protection & orphan market exclu
Page 15 and 16: Licensed pipeline Search & Match Pa
Page 17 and 18: Licensed products Secretin to Lung
Page 19 and 20: Products for licensing MPC at advan
Page 21 and 22: WR Hambrecht+Co. • Founded in 199
Page 23 and 24: Share capital structure A corporate
Page 25 and 26: Financial data - segment reporting
Page 27 and 28: Financial Calendar Next Corporate A
Page 29 and 30: Board Robert Edward Patterson Manag
Page 31 and 32: About us • We started the Company
Page 33: Mondobiotech Holding AG DasKloster

Company presentation - Mondobiotech

Create successful ePaper yourself

Delete template?

Save as template?